Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

• Status: Completed
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: H. Lundbeck A/S
• Treatments: Gaboxadol

Criteria

Inclusion Criteria:

• Diagnosis of insomnia